C9orf72 and amyotrophic lateral sclerosis: More broadly, the observation that NEDP1 inhibition ameliorates ALS-relevant phenotypes driven by distinct genetic etiologies (e.g., SOD1G85R and C9orf72) argues for a central, mutation-independent role of NEDP1 in the elimination of pathological aggregates and in the correction of associated functional deficits.